CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk Healthcare Jubilant Pharmova Ltd

Jubilant Pharmova Ltd

BSE 530019 JUBLPHARMA INE700A01033
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 61 trading days

25 filings · 3 material · busiest 2026-07-16 and 2026-08-10

What it files

Filings

25 in the window

  1. 26 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of AGM

    AGM/EGM / AGM View filing →

  2. 26 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer's Report

    AGM/EGM / AGM View filing →

  3. 17 August 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Scrutinizer's Report

    AGM/EGM / Postal Ballot View filing →

  4. 17 August 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Outcome of Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  5. 11 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publications

    Company Update / Newspaper Publication View filing →

  6. 10 August 2026

    Board Outcome

    Board Meeting Outcome for Meeting Held On August 10, 2026

    outcome of Board meeting

    Board Meeting / Outcome of Board Meeting View filing →

  7. 10 August 2026

    Results

    Un-Audited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2026

    Un-audited Financial Results for the Quarter ended June 30, 2026

    Result / Financial Results View filing →

  8. 10 August 2026

    Press Release

    Press Release / Media Release

    Press Release and presentation

    Company Update / Press Release / Media Release View filing →

  9. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Scheduled For August 10, 2026

    Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....

    Company Update / Board Meeting Rescheduled View filing →

  10. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Investors/ Analysts Meeting

    Company Update / Analyst / Investor Meet View filing →

  11. 30 July 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Scheduled For August 07, 2026

    Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....

    Board Meeting / Board Meeting View filing →

  12. 30 July 2026

    General

    Submission Of Copies Of Newspaper Advertisement Relating To Notice To Shareholders - Transfer Of Equity Shares/Dividend To IEPF

    Submission of Copies of Newspaper Advertisement relating to Notice to Shareholders - Transfer of equity shares/dividend to IEPF

    Company Update / General View filing →

  13. 29 July 2026

    General

    Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday, August 26, 2026 Through Video Conferencing/Other Audio Visual Means.

    Submission of copies of Newspaper Publications - Annual General Meeting of Jubilant Pharmova Limited scheduled to be held on Wednesday, August 26, 2026 through Video Conferencing/Other ....

    Company Update / General View filing →

  14. 29 July 2026

    General

    Communication Sent To Shareholders Relating To Notice Of Transfer To IEPF

    Announcement under Regulation 30 (LODR) - Communication sent to shareholders relating to notice of transfer to IEPF

    Company Update / General View filing →

  15. 16 July 2026

    Other Update

    Disclosure under Regulation 30A of LODR

    Receipt of Rectification Order

    Others View filing →

  16. 16 July 2026

    General

    Approval For Grant Of Stock Options/Rsus/Psus

    Approval for Grant of Stock Options/RSUs/PSUs

    Company Update / General View filing →

  17. 16 July 2026

    General

    Rectification Order From The Inc ome Tax Department

    Rectification order from the Inc ome Tax Department

    Company Update / General View filing →

  18. 2 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliances under Regulation 74 (5) of SEBI (DP) Regulation, 2018, for the quarter ended on June 30, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  19. 1 July 2026

    Newspaper Publication

    Newspaper Publication

    newspaper publication

    Company Update / Newspaper Publication View filing →

  20. 30 June 2026

    General

    Receipt Of Rectification Order

    Receipt of Rectification order

    Company Update / General View filing →

  21. 29 June 2026

    Trading Window

    Closure of Trading Window

    Intimation for the closure of trading window for the quarter ending on June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  22. 26 June 2026

    General

    Tentative Approval For Panto-Prazole Sodium DR

    Tentative approval for Panto-prazole Sodium DR

    Company Update / General View filing →

  23. 24 June 2026

    General

    Rectification Order Received From Tax Department In The Matter Of Jubilant Generics Ltd

    Rectification Order in the matter of Jubilant Generics Limited, Wholly owned step down subsidiary

    Company Update / General View filing →

  24. 19 June 2026

    General

    Completion Of USFDA Inspection

    Completion of USFDA inspection

    Company Update / General View filing →

  25. 19 June 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 19, 2026 for HSB Trustee Company ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →